BOSTON--(BUSINESS WIRE)--Ancora Heart, Inc., a company developing a completely transcatheter device-based therapy to address heart failure (HF), today announced that patients treated with the ...
Sacubitril/valsartan does not change cognitive function, compared with valsartan, in patients with heart failure and mildly reduced or preserved ejection fraction, according to late breaking research ...
A novel immunotherapy strategy using in vivo generation of transient engineered chimeric antigen receptor (CAR) T cells, through the delivery of modified mRNA, can reduce fibrosis and restore cardiac ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Doctors and patients have long known the ...
Editor's note: Find the latest long COVID news and guidance in Medscape's Long COVID Resource Center. Hyperbaric oxygen therapy (HBOT) increased markers of heart function in a small randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback